Tyra Biosciences, Inc.
TYRA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$29,868 | -$28,098 | -$28,147 | -$25,571 |
| Dep. & Amort. | $131 | $140 | $143 | $144 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $6,380 | $6,422 | $6,702 |
| Change in WC | $199 | -$1,394 | -$3,010 | $318 |
| Other Non-Cash | $7,158 | -$708 | -$866 | -$1,183 |
| Operating Cash Flow | -$22,380 | -$23,680 | -$25,458 | -$19,590 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$39 | -$31 | -$14 | -$6 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$65,172 | -$20,106 | -$6,870 | -$38,036 |
| Inv. Sales/Matur. | $50,405 | $41,003 | $38,910 | $45,000 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$14,806 | $20,866 | $32,026 | $6,958 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $647 | $583 | $2,187 | $706 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $647 | $583 | $2,187 | $706 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$36,539 | -$2,231 | $8,755 | -$11,926 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $98,490 | $101,721 | $92,966 | $104,892 |
| End Cash | $61,951 | $99,490 | $101,721 | $92,966 |
| Free Cash Flow | -$22,419 | -$23,711 | -$25,472 | -$19,596 |